| [1] |
SHIMOSEGAWA T, CHARI ST, FRULLONI L, et al. International consensus diagnostic criteria for autoimmune pancreatitis: Guidelines of the International Association of Pancreatology[J]. Pancreas, 2011, 40( 3): 352- 358. DOI: 10.1097/MPA.0b013e3182142fd2. |
| [2] |
DELLA-TORRE E, LANZILLOTTA M, DOGLIONI C. Immunology of IgG4-related disease[J]. Clin Exp Immunol, 2015, 181( 2): 191- 206. DOI: 10.1111/cei.12641. |
| [3] |
SAH RP, CHARI ST, PANNALA R, et al. Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis[J]. Gastroenterology, 2010, 139( 1): 140- 148; quize12- 3. DOI: 10.1053/j.gastro.2010.03.054. |
| [4] |
HART PA, LEVY MJ, SMYRK TC, et al. Clinical profiles and outcomes in idiopathic duct-centric chronic pancreatitis(type 2 autoimmune pancreatitis): The Mayo Clinic experience[J]. Gut, 2016, 65( 10): 1702- 1709. DOI: 10.1136/gutjnl-2015-309275. |
| [5] |
OH D, SONG TJ, MOON SH, et al. Erratum: Type 2 autoimmune pancreatitis(idiopathic duct-centric pancreatitis) highlighting patients presenting as clinical acute pancreatitis: A single-center experience[J]. Gut Liver, 2019, 13( 5): 583. DOI: 10.5009/gnl13051. |
| [6] |
LORENZO D, MAIRE F, STEFANESCU C, et al. Features of autoimmune pancreatitis associated with inflammatory bowel diseases[J]. Clin Gastroenterol Hepatol, 2018, 16( 1): 59- 67. DOI: 10.1016/j.cgh.2017.07.033. |
| [7] |
ZEN Y. Type 2 autoimmune pancreatitis: Consensus and controversies[J]. Gut Liver, 2022, 16( 3): 357- 365. DOI: 10.5009/gnl210241. |
| [8] |
OKAZAKI K, KAWA S, KAMISAWA T, et al. Clinical diagnostic criteria of autoimmune pancreatitis: Revised proposal[J]. J Gastroenterol, 2006, 41( 7): 626- 631. DOI: 10.1007/s00535-006-1868-0. |
| [9] |
CHARI ST, SMYRK TC, LEVY MJ, et al. Diagnosis of autoimmune pancreatitis: The Mayo Clinic experience[J]. Clin Gastroenterol Hepatol, 2006, 4( 8): 1010- 1016;quiz934. DOI: 10.1016/j.cgh.2006.05.017. |
| [10] |
CHARI ST. Diagnosis of autoimmune pancreatitis using its five cardinal features: Introducing the Mayo Clinic’s HISORt criteria[J]. J Gastroenterol, 2007, 42( Suppl 18): 39- 41. DOI: 10.1007/s00535-007-2046-8. |
| [11] |
MARUYAMA M, WATANABE T, KANAI K, et al. International consensus diagnostic criteria for autoimmune pancreatitis and its Japanese amendment have improved diagnostic ability over existing criteria[J]. Gastroenterol Res Pract, 2013, 2013: 456965. DOI: 10.1155/2013/456965. |
| [12] |
KHANDELWAL A, INOUE D, TAKAHASHI N. Autoimmune pancreatitis: An update[J]. Abdom Radiol, 2020, 45( 5): 1359- 1370. DOI: 10.1007/s00261-019-02275-x. |
| [13] |
ZEN Y, NAKANUMA Y. IgG4-related disease: A cross-sectional study of 114 cases[J]. Am J Surg Pathol, 2010, 34( 12): 1812- 1819. DOI: 10.1097/PAS.0b013e3181f7266b. |
| [14] |
ZHANG LZ, NOTOHARA K, LEVY MJ, et al. IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis[J]. Mod Pathol, 2007, 20( 1): 23- 28. DOI: 10.1038/modpathol.3800689. |
| [15] |
DESHPANDE V, ZEN Y, CHAN JK, et al. Consensus statement on the pathology of IgG4-related disease[J]. Mod Pathol, 2012, 25( 9): 1181- 1192. DOI: 10.1038/modpathol.2012.72. |
| [16] |
SATO Y, KOJIMA M, TAKATA K, et al. Systemic IgG4-related lymphadenopathy: A clinical and pathologic comparison to multicentric Castleman’s disease[J]. Mod Pathol, 2009, 22( 4): 589- 599. DOI: 10.1038/modpathol.2009.17. |
| [17] |
KITAGAWA S, ZEN Y, HARADA K, et al. Abundant IgG4-positive plasma cell infiltration characterizes chronic sclerosing sialadenitis(Küttner’s tumor)[J]. Am J Surg Pathol, 2005, 29( 6): 783- 791. DOI: 10.1097/01.pas.0000164031.59940.fc. |
| [18] |
SATO Y, KOJIMA M, TAKATA K, et al. Multicentric Castleman’s disease with abundant IgG4-positive cells: A clinical and pathological analysis of six cases[J]. J Clin Pathol, 2010, 63( 12): 1084- 1089. DOI: 10.1136/jcp.2010.082958. |
| [19] |
ZEN Y. Autoimmune pancreatitis: Biopsy interpretation and differential diagnosis[J]. Semin Diagn Pathol, 2024, 41( 2): 79- 87. DOI: 10.1053/j.semdp.2024.01.001. |
| [20] |
KAWAKAMI H, ZEN Y, KUWATANI M, et al. IgG4-related sclerosing cholangitis and autoimmune pancreatitis: Histological assessment of biopsies from Vater’s ampulla and the bile duct[J]. J Gastroenterol Hepatol, 2010, 25( 10): 1648- 1655. DOI: 10.1111/j.1440-1746.2010.06346.x. |
| [21] |
CHHODA A, RUSTAGI T. EUS-guided needle biopsy for autoimmune pancreatitis[J]. Clin J Gastroenterol, 2020, 13( 5): 669- 677. DOI: 10.1007/s12328-020-01153-0. |
| [22] |
YOON SB, MOON SH, SONG TJ, et al. Endoscopic ultrasound-guided fine needle aspiration versus biopsy for diagnosis of autoimmune pancreatitis: Systematic review and comparative meta-analysis[J]. Dig Endosc, 2021, 33( 7): 1024- 1033. DOI: 10.1111/den.13866. |
| [23] |
FACCIORUSSO A, BARRESI L, CANNIZZARO R, et al. Diagnostic yield of endoscopic ultrasound-guided tissue acquisition in autoimmune pancreatitis: A systematic review and meta-analysis[J]. Endosc Int Open, 2021, 9( 1): E66- E75. DOI: 10.1055/a-1293-7279. |
| [24] |
SHIMOSEGAWA T, Working Group Members of the Japan Pancreas Society, Health and Welfare of Japan Research Committee for Intractable Pancreatic Disease by the Ministry of Labor. The amendment of the Clinical Diagnostic Criteria in Japan(JPS2011) in response to the proposal of the International Consensus of Diagnostic Criteria(ICDC) for autoimmune pancreatitis[J]. Pancreas, 2012, 41( 8): 1341- 1342. DOI: 10.1097/MPA.0b013e3182706ed5. |
| [25] |
KAWA S, KAMISAWA T, NOTOHARA K, et al. Japanese clinical diagnostic criteria for autoimmune pancreatitis, 2018: Revision of Japanese clinical diagnostic criteria for autoimmune pancreatitis, 2011[J]. Pancreas, 2020, 49( 1): e13- e14. DOI: 10.1097/MPA.0000000000001443. |
| [26] |
NOTOHARA K. Biopsy diagnosis of type 1 autoimmune pancreatitis: Does it bring a conclusion or confusion?[J]. DEN Open, 2022, 2( 1): e82. DOI: 10.1002/deo2.82. |
| [27] |
CAO L, WANG Y, WANG JL, et al. The role of EUS-guided fine needle aspiration in autoimmune pancreatitis: A single center prospective study[J]. Scand J Gastroenterol, 2018, 53( 12): 1604- 1610. DOI: 10.1080/00365521.2018.1534137. |
| [28] |
KANNO A, MASAMUNE A, FUJISHIMA F, et al. Diagnosis of autoimmune pancreatitis by EUS-guided FNA using a 22-gauge needle: A prospective multicenter study[J]. Gastrointest Endosc, 2016, 84( 5): 797- 804. e 1. DOI: 10.1016/j.gie.2016.03.1511. |
| [29] |
NOTOHARA K, KAMISAWA T, KANNO A, et al. Efficacy and limitations of the histological diagnosis of type 1 autoimmune pancreatitis with endoscopic ultrasound-guided fine needle biopsy with large tissue amounts[J]. Pancreatology, 2020, 20( 5): 834- 843. DOI: 10.1016/j.pan.2020.05.026. |
| [30] |
NOTOHARA K, KAMISAWA T, FUKUSHIMA N, et al. Guidance for diagnosing autoimmune pancreatitis with biopsy tissues[J]. Pathol Int, 2020, 70( 10): 699- 711. DOI: 10.1111/pin.12994. |
| [31] |
BASTURK O, HONG SM, WOOD LD, et al. A revised classification system and recommendations from the Baltimore consensus meeting for neoplastic precursor lesions in the pancreas[J]. Am J Surg Pathol, 2015, 39( 12): 1730- 1741. DOI: 10.1097/PAS.0000000000000533. |
| [32] |
DESHPANDE V, GUPTA R, SAINANI N, et al. Subclassification of autoimmune pancreatitis: A histologic classification with clinical significance[J]. Am J Surg Pathol, 2011, 35( 1): 26- 35. DOI: 10.1097/PAS.0b013e3182027717. |
| [33] |
HAYASHI H, MIURA S, FUJISHIMA F, et al. Utility of endoscopic ultrasound-guided fine-needle aspiration and biopsy for histological diagnosis of type 2 autoimmune pancreatitis[J]. Diagnostics, 2022, 12( 10): 2464. DOI: 10.3390/diagnostics12102464. |
| [34] |
CHARI ST, KLOEPPEL G, ZHANG LZ, et al. Histopathologic and clinical subtypes of autoimmune pancreatitis: The Honolulu consensus document[J]. Pancreatology, 2010, 10( 6): 664- 672. DOI: 10.1159/000318809. |
| [35] |
SAYED AHMED A, ABREO M, THOMAS A, et al. Type 3 autoimmune pancreatitis(immune checkpoint inhibitor-induced pancreatitis)[J]. Curr Opin Gastroenterol, 2022, 38( 5): 516- 520. DOI: 10.1097/MOG.0000000000000873. |
DownLoad:
